WILMINGTON, Mass. & MARCO ISLAND, Fla.--(BUSINESS WIRE)--Kapa Biosystems, Inc., a leading supplier of reagents for the life science market, today announced the launch of products that improve performance and workflows for genomic research. The new suite of products enables researchers to apply the latest next-generation sequencing (NGS) technologies more effectively to millions of low quality and challenging samples, such as formalin-fixed paraffin-embedded (FFPE) tissue common in cancer profiling. Kapa Biosystems and its customers will present data supporting the new products during the 2014 Advances in Genome Biology and Technology (AGBT) Meeting in Marco Island, Fla. on February 12-15.
Help employers find you! Check out all the jobs and post your resume.
